Our group has recently described the antiproliferative and pro-apoptotic effects of CA in K562 cells, a BCR-ABL positive human CML cell line, on which it also enhanced the antitumor effect of Imatinib [21]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.